Back to Trial Categories

Cancer Trials

Disease: Renal
Phase I/II Study of BNC105P in Combination with Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors. - GU09-145
Status: Open to Accrual 1-20-2010; 3 of 138 accrued.
More Details